Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

R. I. Lalisang, Frans L. G. Erdkamp, C. J. Rodenburg, C. T. A. M. Knibbeler-van Rossum, J.W.R. Nortier, A. van Bochove, P. H. Th. J. Slee, E.E. Voest, J.A. Wils, J. Wals, Olaf J. L. Loosveld, A. E. M. Smals, G.H. Blijham, V. C. G. Tjan-Heijnen, H. C. Schouten

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)437-445
JournalBreast Cancer Research and Treatment
Volume128
Issue number2
DOIs
Publication statusPublished - Jul 2011

Keywords

  • Combination chemotherapy
  • Breast neoplasm's
  • Dose-dense
  • Dose-intensive
  • Epirubicin
  • Paclitaxel

Cite this

Lalisang, R. I., Erdkamp, F. L. G., Rodenburg, C. J., Knibbeler-van Rossum, C. T. A. M., Nortier, J. W. R., van Bochove, A., Slee, P. H. T. J., Voest, E. E., Wils, J. A., Wals, J., Loosveld, O. J. L., Smals, A. E. M., Blijham, G. H., Tjan-Heijnen, V. C. G., & Schouten, H. C. (2011). Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy. Breast Cancer Research and Treatment, 128(2), 437-445. https://doi.org/10.1007/s10549-011-1558-3